Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol
2002; 39: 1890–1900.
King, TD, Thompson, SL, Steiner, C, et al. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA
1976; 235: 2506–2509.
Roos-Hesselink, JW, Meijboom, FJ, Spitaels, SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J
2003; 24: 190–197.
Du, ZD, Hijazi, ZM, Kleinman, CS, et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol
2002; 39: 1836–1844.
Bialkowski, J, Karwot, B, Szkutnik, M, et al. Closure of atrial septal defects in children: surgery versus Amplatzer device implantation. Tex Heart Inst J
2004; 31: 220–223.
Berger, F, Vogel, M, Alexi-Meskishvili, V, et al. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg
1999; 118: 674–678; discussion 78–80.
Romanelli, G, Harper, RW, Mottram, PM. Transcatheter closure of secundum atrial septal defects: results in patients with large and extreme defects. Heart Lung Circ
2014; 23: 127–131.
Varma, C, Benson, LN, Silversides, C, et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc Interv
2004; 61: 131–139.
Moore, J, Hegde, S, El-Said, H, et al. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv
2013; 6: 433–442.
Divekar, A, Gaamangwe, T, Shaikh, N, et al. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol
2005; 45: 1213–1218.
DiBardino, DJ, McElhinney, DB, Kaza, AK, et al. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg
2009; 137: 1334–1341.
Circulatory System Devices Advisory Panel. ed. FDA Executive Summary Memorandum. Transcatheter ASD Occluders: Clinical Update and Review of Events. Circulatory System Devices Advisory Panel; 2012 24 May 2012; Gaithersburg, MD. Center for Devices and Radiological Health. US Food and Drug Administration, Gaithersburg, Maryland.
El-Said, HG, Moore, JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations?
Catheter Cardiovasc Interv
2009; 73: 925–930.
14. AGA Medical Corporation. AMPLATZER® Septal Occluder and Delivery System. Physician Manual. St Jude Medical, St Paul, Minnesota, 2001.
Everett, AD, Jennings, J, Sibinga, E, et al. Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol
2009; 30: 240–247.
Haas, NA, Soetemann, DB, Ates, I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: The IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv
2016; 88: 571–581.
Chessa, M, Carminati, M, Butera, G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol
2002; 39: 1061–1065.
Levi, DS, Moore, JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv
2004; 61: 543–547.
Johnson, JN, Marquardt, ML, Ackerman, MJ, et al. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Catheter Cardiovasc Interv
2011; 78: 254–261.
Amin, Z, Hijazi, ZM, Bass, JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv
2004; 63: 496–502.
McElhinney, DB, Quartermain, MD, Kenny, D, et al. Relative risk factors for cardiac erosion following transcatheter closure of Atrial septal defects: a case-control study. Circulation
2016; 133: 1738–1746.